CLIA labs are challenged and frustrated with inconsistent analytical results, and poor functional performance results using their general lab reagents. As you know, the same reagents are sold to multiple other industries, which are then utilized for varied customer types, and a multitude of other applications.

Testing each reagent prior to use is a CLIA required action, and it can also be a costly and time consuming process if you don’t have confidence in the reagent and the supplier. Inconsistencies in reagents could have serious implications for your patients regarding their diagnosis and potential treatment. Additionally, manufacturers of Diagnostic and Molecular Diagnostic assays and reagents need a reliable and proven partner to provide them with the regulatory framework, validation needs, consistency, and quality driven metrics that will support their Diagnostic tool.

In response to those concerns and the specific needs of the Life Science market, AmericanBio has developed its Next Generation of Reproducible Reactions with our CLIA Grade product line and CLIA Grade Custom Manufacturing Services.

View all CLIA Grade Products